Your Patients

Artificial Pancreas Can Prevent Dangerously Low Blood Sugar in People with Type 1 Diabetes

New system reduces the risk of exercise-related hypoglycemia A new artificial pancreas system can prevent hypoglycemia—episodes of dangerously low blood sugar—during and after heavy exercise in people with type 1 diabetes, according to a small study published in The Journal of Clinical Endocrinology & Metabolism. Despite advances in treatment, blood sugar control in type 1 diabetes remains challenging. The artificial pancreas has the potential to...

Lilly Launches Initiative “Know Before the Low” to Help Patients with Diabetes Recognize and Share Symptoms

Singer/songwriter Crystal Bowersox kicks off the educational initiative by encouraging people to educate their support network and develop a plan for low blood sugar and very low blood sugar emergencies Eli Lilly and Company launched a new initiative earlier this summer to raise awareness about being prepared for these unpredictable conditions. With Know Before the...

Next-Generation Integrated Continuous Glucose Monitor Now Available Following FDA Clearance

An integrated continuous glucose monitor (iCGM) is now available for adults and now children (4+ years) living with diabetes, following its clearance in June from the U.S. Food and Drug Administration (FDA). Abbot is marketing this new technology as the FreeStyle® Libre 2. The FreeStyle Libre 2 system uses Bluetooth to automatically alerts users when...

Up, Up, and Away: How Drones Could Revolutionize Insulin Delivery

Drones have delivered medications and other medical supplies to people in underdeveloped areas, but what of their use in times of disaster or even a pandemic to patients with chronic conditions such as diabetes? A multidisciplinary team has taken the first step to achieving insulin delivery via drone. The Aran Islands, located about 12 miles...

FDA Approves New Fast-Acting Insulin

The U.S. Food and Drug Administration (FDA) has approved insulin lispro-aabc injection, 100 units/mL and 200 units/mL, a new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes. Eli Lilly and Company is marketing the drug as Lyumjev™. Lyumjev is a novel formulation of insulin lispro, developed to...

Virtual Endocrinology: The Rise of Telemedicine During COVID-19

How clinicians treat patients has been drastically reimagined during the COVID-19 pandemic due to social distancing requirements. Since patients still need to see their doctors one way or another, telemedicine has filled the gap and has been embraced by both the healthcare community and patients alike. Chirag R. Kapadia, MD, is an endocrinologist at Phoenix...

Viral Load: A Look at One Endocrinologist’s Practice During the COVID-19 Crisis

Via an online video conference with Endocrine News, Mihail “Misha” Zilbermint, MD, discusses how the COVID-19 virus has changed the way he practices medicine in a hospital setting, and how his approach to treating patients may be changed forever. One of the common terms that has been used to describe everything from the way...

FDA Approves First Treatment for Thyroid Eye Disease

In January, Endocrine News reported on the possible upcoming availability of teprotumumab as a promising treatment for of thyroid eye disease (TED), a serious, progressive and vision-threatening rare autoimmune disease that is associated with proptosis (eye bulging), diplopia (double vision), blurred vision, pain, inflammation, and facial disfigurement. Up to 50% of patients with Graves’ disease...

Your Patients

Endocrine news on twitter